A growing elderly arthritic population and improving access to health care will support reconstructive implant procedure volume expansion, driving growth in the Asia Pacific large-joint reconstructive implant market through 2027. However, economic constraints in the emerging Chinese and Indian markets will hinder adoption of novel technologies like 3-D–printed implants and robotic-assisted surgeries and limit market revenue growth to some degree.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for reconstructive joint implants in the Asia Pacific countries across a 10-year period.
The Asia Pacific market for large-joint reconstructive implants remains relatively underpenetrated.
What factors are expected to change to enable market expansion in this space through 2027?
What role has alternative treatments played in limiting this market?
The introduction of government-mandated price controls for reconstructive knee implants in India in 2017 has dramatically reduced ASPs for these products in the country.
How will knee implant price controls influence procedure volumes and market revenues in the Indian market?
What impact will the price cap in India have on the overall Asia Pacific knee implant market?
Cost constraints on health care facilities in the Asia Pacific region hinder adoption of technological advances in large-joint reconstructive surgery, such as robotic-assisted surgeries.
How quickly will these technological advancements be adopted across Asia Pacific countries, and how will they impact the market for large-joint reconstructive implants?
Which innovations will be adopted and which ones will remain unpopular in the region and why?
MNCs dominate the Asia Pacific large-joint reconstructive implant market.
What strategies are local manufacturers using to compete with the leading MNCs?
- Large-Joint Reconstructive Implants - Market Insights - Asia Pacific
Author(s): Meenu Sankar, MS
Meenu Sankar is a research associate within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in large-joint reconstructive implants. Meenu holds a Bachelor's degree in Pharmaceutical Sciences from Manipal University and a Master's degree in Biomedicine from The University of Skövde.
Follow Meenu on Twitter:@meenu_sankarDRG